|
⚲
|
| Lux Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001366282 |
| Sale | 2009-10-15 ($49.9 M Offered, $37.9 M Sold) |
| Fund | |
| Phone | 2019460551 |
| Address | Harborside Financial Center Plaza 10 Jersey City, 07302 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| A Atwell | |
| Lutz Giebel | |
| Eddy Anglade | |
| Brett Skolnik | |
| Axel Bolte | |
| Paul Chaney | |
| David Schnell | |
| Ulrich Grau | |
| David Guyer | |
| Thomas Dyrberg |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
KRE MREG Main Line Venture REIT LLC
✚
|
0.0 | |
|
Krepiakevich Terry
✚
|
0.0 | |
|
KRE Quincy REIT Manager LLC
✚
|
0.0 | |
|
Swing Therapeutics, Inc.
✚
|
0.0 | |
|
Swordfish Holdings LLC
✚
|
0.0 | |
|
Swytchboard, Inc.
✚
|
0.0 | |
|
KRE Southline REIT Holdings LLC
✚
|
0.0 | |
|
Krevolin Bret H
✚
|
0.0 | |
|
Krieger Bernd R.
✚
|
0.0 | |
|
Qunnect, LLC
✚
|
0.0 |